What technical signals does Entera Bio (ENTX) have?

Entera Bio current technical signals: no active technical signal.

Is Entera Bio a cup-and-handle pattern?

No. Entera Bio has no valid Cup signal right now.

What published figures are available for Entera Bio?

Market cap: $131.15M. Trailing 12 months PER: -8.5×. Latest quarter PBR: 19.86×. Dividend yield: 0.00%.

← Signal Board

Entera Bio stock price

엔테라 바이오NASDAQ:ENTX · Nasdaq · Healthcare

$2.86-1.04%

2026-10-02 close

Today's signals · No active technical signal.

Signal details →

Entera Bio last closed at $2.86 (-1.04%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -8.5×. Its overall grade ranks 498 of 739 stocks in Healthcare.

About this company

Entera Bio last closed at $2.86 (-1.04%) on 2026-10-02. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall C+ · 498/739

Valuation grade A-

Details →

Related stocks

AmgenCompetitor
골다공증·대사성 뼈질환 등 바이오 신약 개발 영역에서 경쟁 가능성이 큼
Eli LillyCompetitor
비만·대사질환 및 관련 혁신신약 파이프라인에서 경쟁 구도 가능
PfizerCompetitor
내분비·희귀질환 바이오치료제 시장의 대형 경쟁사

Details →

About Entera Bio

What technical signals does Entera Bio (ENTX) have?: Entera Bio current technical signals: no active technical signal.
Is Entera Bio a cup-and-handle pattern?: No. Entera Bio has no valid Cup signal right now.
What published figures are available for Entera Bio?: Market cap: $131.15M. Trailing 12 months PER: -8.5×. Latest quarter PBR: 19.86×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-04 dataset

Turn what you saw on this name into a strategy

Ask Q about Entera Bio, or open the plan table on the main site.

Ask Q ↗See plans ↗

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Quantus Signal · live data · not investment advice · Privacy Policy